Literature DB >> 4180869

Cyclophosphamide in multiple sclerosis.

P Millac, H Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4180869     DOI： 10.1016/s0140-6736(69)91788-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Cyclophosphamide for multiple sclerosis.

Authors:  L La Mantia; C Milanese; N Mascoli; R D'Amico; B Weinstock-Guttman
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

2.  Cyclophosphamide in exacerbations of multiple sclerosis. Therapeutic trial and a strategy for pilot drug studies.

Authors:  D A Drachman; P Y Paterson; R T Schmidt; R F Spehlmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-06       Impact factor: 10.154

3.  Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance.

Authors:  Daniel M Harrison; Douglas E Gladstone; Edward Hammond; Jeffrey Cheng; Richard J Jones; Robert A Brodsky; Douglas Kerr; Justin C McArthur; Adam Kaplin
Journal:  Mult Scler       Date:  2011-08-24       Impact factor: 6.312

4.  Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study.

Authors:  W H Likosky; B Fireman; R Elmore; G Eno; K Gale; G B Goode; K Ikeda; J Laster; C Mosher; J Rozance
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-12       Impact factor: 10.154

Review 5.  Comparative activity of ifosfamide and cyclophosphamide.

Authors:  W Brade; S Seeber; K Herdrich
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

6.  Clinical use of immunosuppressive drugs: part II.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

7.  Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years.

Authors:  R E Gonsette; L Demonty; P Delmotte
Journal:  J Neurol       Date:  1977-02-17       Impact factor: 4.849

8.  Lights and shadows of cyclophosphamide in the treatment of multiple sclerosis.

Authors:  Francesco Patti; Salvatore Lo Fermo
Journal:  Autoimmune Dis       Date:  2011-03-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.